Dr. Ana C. Garrido-Castro
Claim this profileDana Farber Cancer Institute
Area of expertise
Breast Cancer
Ana C. Garrido-Castro has run 4 trials for Breast Cancer. Some of their research focus areas include:
Breast Cancer
Ana C. Garrido-Castro has run 2 trials for Breast cancer. Some of their research focus areas include:
Affiliated Hospitals
Dana Farber Cancer Institute
Dana-Farber - Harvard Cancer Center LAO
Clinical Trials Ana C. Garrido-Castro is currently running
Dato-DXd + T-DXd
for Breast Cancer
The purpose of this study is to test the safety and effectiveness of the sequence of two investigational drugs (trastuzumab deruxtecan followed by datopotamab deruxtecan, or datopotamab deruxtecan followed by trastuzumab deruxtecan) to learn whether the treatment works in treating HER2-negative (HER2-low or HER2-0) metastatic breast cancer. The names of the study drugs involved in this study are: * Datopotamab deruxtecan (a type of antibody drug conjugate) * Trastuzumab deruxtecan (a type of antibody drug conjugate)
Recruiting
1 award
Phase 2
7 criteria
Sacituzumab Govitecan + Pembrolizumab
for Triple Negative Breast Cancer
This research study involves testing the safety and efficacy of an investigational intervention for patients with triple-negative breast cancer (TNBC) that has spread, or metastasized, to other parts the body and is PD-L1-negative. The names of the study interventions involved in this study are: * Sacituzumab govitecan (Trodelvy™;IMMU-132) * Pembrolizumab (Keytruda®; MK-3475)
Recruiting
1 award
Phase 2
15 criteria
More about Ana C. Garrido-Castro
Clinical Trial Related
1 year of experience running clinical trials · Led 4 trials as a Principal Investigator · 3 Active Clinical Trials
Treatments Ana C. Garrido-Castro has experience with
- Pembrolizumab
- Sacituzumab Govitecan
- Datopotamab Deruxtecan
- Trastuzumab Deruxtecan
- Nab-paclitaxel
- ZEN-3694
Breakdown of trials Ana C. Garrido-Castro has run
Breast Cancer
Breast cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Ana C. Garrido-Castro specialize in?
Ana C. Garrido-Castro focuses on Breast Cancer and Breast cancer. In particular, much of their work with Breast Cancer has involved Stage IV patients, or patients who are Stage III.
Is Ana C. Garrido-Castro currently recruiting for clinical trials?
Yes, Ana C. Garrido-Castro is currently recruiting for 3 clinical trials in Boston Massachusetts. If you're interested in participating, you should apply.
Are there any treatments that Ana C. Garrido-Castro has studied deeply?
Yes, Ana C. Garrido-Castro has studied treatments such as Pembrolizumab, Sacituzumab Govitecan, Datopotamab Deruxtecan.
What is the best way to schedule an appointment with Ana C. Garrido-Castro?
Apply for one of the trials that Ana C. Garrido-Castro is conducting.
What is the office address of Ana C. Garrido-Castro?
The office of Ana C. Garrido-Castro is located at: Dana Farber Cancer Institute, Boston, Massachusetts 02215 United States. This is the address for their practice at the Dana Farber Cancer Institute.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.